|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02157 LEPU BIO-B
Nominal 
3.200 -0.030 (-0.929%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 133,283 | -13.201% | 225,352 | 15,572 | 0 | 0 |
| Cost of Sales | (21,042) | 265.630% | (28,277) | (2,005) | -- | -- |
| Gross Profit | 112,241 | -24.058% | 197,075 | 13,567 | -- | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (124) | -- | 174,976 | (62,816) | (76,285) | (77,991) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (7,037) | -67.271% | (27,341) | (32,231) | (17,695) | (12,084) | |
| Profit / (Loss) before Taxation | (196,966) | 38.802% | (30,301) | (699,441) | (1,028,869) | (613,448) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 4,536 | -- | 8,205 | 10,389 | 17,873 | 31,599 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (192,430) | 35.606% | (22,096) | (689,052) | (1,010,996) | (581,849) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 5,893 | 144.726% | 7,756 | (37,272) | 1,538 | 81,013 |
| Depreciation & Amortisation | 47,135 | -8.543% | 102,572 | 95,446 | 95,246 | 84,114 |
| Directors' Emoluments | -- | -- | 15,291 | 18,828 | 25,525 | 5,226 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -12.000 | 33.333% | -1.000 | -42.000 | -66.000 | -51.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.151) | (0.293) | (0.409) | (0.372) |
| NBV per share ($) | 0.535 | -- | 0.540 | 0.543 | -- | -- |
| Remarks: | Real time quote last updated: 14/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -192,430,000 |
| %Change | 35.606% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 0.535 |